
In a significant development concerning healthcare fraud, a Seattle-based laboratory, FidaLab, LLC, has agreed to a $2 million settlement with the Department of Justice. The resolution follows allegations that the company was involved in overcharging Medicare and other government health programs. The federal probe, spearheaded by the Health and Human Services Office of Inspector General (HHS-OIG), uncovered that FidaLab billed for a series of Urinary Tract Infection tests using multiple billing codes rather than a single code after their panel billing request was denied, according to the U.S. Attorney's Office for the Western District of Washington.
Addressing the issue, U.S. Attorney Charles Neil Floyd emphasized the importance of integrity in healthcare billing, "We all have a stake in keeping healthcare costs under control," he said. "Manipulating billing codes to overcharge for tests is an obvious area where we need to root out fraud. This case should be a warning to other companies to make sure they are billing for healthcare services appropriately." Though FidaLab did not admit wrongdoing, the settlement indicates a commitment to addressing discrepancies in billing practices.
The U.S. Attorney's Office announcement also included comments from Robb R. Breeden, Acting Special Agent in Charge with HHS-OIG, underscoring the detrimental effects of such practices on the healthcare system. "Laboratories entrusted with taxpayer-funded health care programs must submit truthful and accurate claims," Breeden asserted. "Submitting false laboratory testing claims wastes critical resources and undermines trust in our health care system."
FidaLab has also agreed in the settlement not to seek payment for the unallowed costs from any of the patients involved in these health care billings. The investigation, which resulted in this settlement, was conducted by the Health and Human Services Office of Inspector General, with Assistant United States Attorney Matt Waldrop and investigative analyst Ryan Hardy playing significant roles in the negotiations. The press contact for the U.S. Attorney’s Office, Emily Langlie, offered details on the settlement and can be reached at (206) 553-4110 or via email at [email protected] for further queries.









